The estimated Net Worth of Family Lpkoski Robert Ckosk... is at least $213 Thousand dollars as of 14 September 2018. Family Ckosk owns over 169,050 units of Oragenics Inc stock worth over $138,920 and over the last 11 years Family sold OGEN stock worth over $74,468.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Family Ckosk OGEN stock SEC Form 4 insiders trading
Family has made over 11 trades of the Oragenics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Family bought 169,050 units of OGEN stock worth $71,001 on 14 September 2018.
The largest trade Family's ever made was buying 169,050 units of Oragenics Inc stock on 14 September 2018 worth over $71,001. On average, Family trades about 16,106 units every 103 days since 2014. As of 14 September 2018 Family still owns at least 277,839 units of Oragenics Inc stock.
You can see the complete history of Family Ckosk stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Oragenics Inc
Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez, and Robert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.
What does Oragenics Inc do?
oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.
What does Oragenics Inc's logo look like?
Complete history of Family Ckosk stock trades at Oragenics Inc
Oragenics Inc executives and stock owners
Oragenics Inc executives and other stock owners filed with the SEC include:
-
Michael O. Sullivan CPA,
CFO, Sec., Treasurer & Interim Principal Exec. Officer -
Dr. Martin Handfield M.Sc., Ph.D.,
Sr. VP of Discovery Research -
Michael Sullivan,
Chief Financial Officer, Treasurer, Secretary -
Dr. Frederick W. Telling Ph.D.,
Exec. Chairman -
Charles Pope,
Independent Director -
Robert Koski,
Independent Director -
Alan Dunton,
Independent Director -
Kim Murphy,
Director -
Alan Joslyn,
President, Chief Executive Officer, Director -
Frederick Telling,
Independent Chairman of the Board -
Dr. Raman Bedi,
Chairman of International Scientific Advisory Board and Sr. Consultant -
Joseph Hernandez,
10% owner -
John P Gandolfo,
Director -
Bruce A. Sr. Cassidy,
Director -
Randal Jintrexon Corp Kirk,
-
Fred Telling,
Director -
Family Lpkoski Robert Ckosk...,
-
Janet Huffman,
CFO, Secretary and Treasurer -
Christine L Koski,
-
Family Lp Koski,
-
Thomas L Koski,
-
Beverly Koski,
-
Robert Ckoski Christine Lko...,
-
Family Lpkoski Christine Lk...,
-
John N Bonfiglio,
President and CEO -
Family Lpkoski Beverlykoski...,
-
J Michael Redmond,
President -
Robert C Koski,
Director